Antiplatelet Effects of Garlic and Chitosan: a Comparative Study between Fermented and Non-Fermented Preparations
Open Access
- 30 September 2018
- journal article
- Published by The Korean Society for Biomedical Laboratory Sciences in Biomedical Science Letters
- Vol. 24 (3) , 280-284
Abstract
The incidence of cardiovascular diseases (CVDs) is increasing rapidly in developed countries, with CVDs now representing the leading cause of morbidity and mortality. Natural products and ethnomedicines have been shown to reduce the risk of CVDs. Garlic is a medicinal plant used throughout the world for its anti-inflammatory, antioxidant, and antiplatelet activities. Chitosan is a natural polysaccharide obtained from chitin, and derivatives of chitosan have been shown to inhibit platelet aggregation and adhesion. We hypothesized that fermented preparations of these products may possess stronger antiplatelet effects than the non-fermented forms owing to the increased bioavailability of the bioactive compounds produced during fermentation. Therefore, we compared these compounds via in vitro and ex vivo platelet aggregation assays by using standard light transmission aggregometry and ex vivo granule secretions from rat platelets. We found that fermented preparations exerted more potent and significant inhibition of platelet aggregation both in vitro and ex vivo. Likewise, ATP release from dense granules of platelets was also significantly inhibited in fermented preparation-treated rat platelets compared to that in non-fermented preparation-treated ones. We concluded that fermented preparations exerted more potent effects on platelet function both in vitro and ex vivo, possibly as a result of the increased bioavailability of active compounds produced during fermentation. We therefore suggest that fermented products may be potent therapeutics against platelet-related CVDs and can be used as antiplatelet and antithrombotic agents.Keywords
This publication has 17 references indexed in Scilit:
- Traditional herbs: a remedy for cardiovascular disordersPhytomedicine, 2016
- Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathwayJournal of Ethnopharmacology, 2014
- Pathology of human plaque vulnerability: Mechanisms and consequences of intraplaque haemorrhagesAtherosclerosis, 2014
- Bioavailability of bioactive food compounds: a challenging journey to bioefficacyBritish Journal of Clinical Pharmacology, 2013
- Fermenting Red Ginseng Enhances Its Safety and Efficacy as a Novel Skin Care Anti-Aging Ingredient: In Vitro and Animal StudyJournal of Medicinal Food, 2012
- Stable nanomicelles based on chitosan derivative: In vitro antiplatelet aggregation and adhesion propertiesCarbohydrate Polymers, 2012
- Future innovations in anti‐platelet therapiesBritish Journal of Pharmacology, 2008
- Adhesion Mechanisms in Platelet FunctionCirculation Research, 2007
- Dietary patterns associated with risk factors for cardiovascular disease in healthy US adultsThe American Journal of Clinical Nutrition, 2003
- Dietary components and human platelet activityPlatelets, 2002